POLD1 and central nervous system cancer: Features of defective polymerase proofreading, i.e. high TMB, presence of POLE/POLD1 variant-associated mutational signatures or multinucleated cells/enlarged nuclei, and increased immune cell infiltrate, were detected in 13/15 (87%) gliomas from patients carrying POLE/POLD1 variants